Trial · NCT06694818
The Impact of Attentive System on Sleep Reactivity
NCT06694818, Not applicable, Completed, IRCCS San Raffaele
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. The Impact of Attentive System on Sleep Reactivity. Trials, record NCT06694818. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06694818
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- The Impact of Attentive System on Sleep Reactivity
- NCT number
- NCT06694818
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 40 participants, actual
- Lead sponsor
- IRCCS San Raffaele
- Conditions
- Insomnia Due to Anxiety and Fear
- Interventions
- trauma film paradigm
- First posted
- 2024-11-19
- Last updated
- 2026-10-13
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Sleep Efficiency (%)_PSG recording | From enrollment to 4 days | Using the portable Sleep Profiler device, the investigators will capture data on participants' sleep in their home environment, ensuring an ecologically valid setting. sleep efficiency is expressed in % reporting the ratio between time in bed and total sleep time (range 0-100). |
| Primary | Sleep Diary_Sleep efficiency (%) | From enrollment tothe end of study at 18 days | Participants will complete a daily Sleep Diary for 18 days, recording information each morning within 10 minutes of waking. This diary will provide data on participants' subjective sleep quality, including indicators such as perceived Sleep Efficiency (pecentual).Sleep efficiency is expressed in % reporting the ratio between time in bed and total sleep time (range 0-100). |
| Primary | Neuropsychological Attention Assessment_Reaction time (ms) | From enrollment to 4 days | The Attention Network Test (ANT), which evaluates reaction times (millisec) related to executive functions. |
| Primary | Polysomnographic Recording_REM Phase (%) | From enrollment to 4 days | Using the portable Sleep Profiler device, the investigators will capture data on participants' sleep in their home environment, ensuring an ecologically valid setting. REM % is expressed as ratio between toital sleep time and times spent during REM sleep period. |
| Secondary | Neuropsychological Attention Assessment_stroop reaction time (ms) | From enrollment to 4 days | The Stroop Task evaluates the reaction time in millisec. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests2
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Attention Network Test | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06694818
GET https://conductscience.org/api/trials/v1/NCT06694818/registered